PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) will report first-quarter 2026 financial results on Thursday, May 7, 2026, before the opening of U.S. financial markets.
The company will host a conference call and webcast at 8:30 a.m. Eastern Time the same day to discuss the results.
Participants can join the call by dialing 800-274-8461 domestically or 203-518-9814 internationally and using passcode HRMYQ126.
A live and archived webcast will be available on the company’s investor relations website at https://ir.harmonybiosciences.com/.
Harmony Biosciences is a pharmaceutical company focused on developing and commercializing therapies for patients with rare neurological diseases.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.